1. Home
  2. HWC vs BLLN Comparison

HWC vs BLLN Comparison

Compare HWC & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hancock Whitney Corporation

HWC

Hancock Whitney Corporation

HOLD

Current Price

$75.18

Market Cap

5.6B

Sector

Finance

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$118.17

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWC
BLLN
Founded
1883
2016
Country
United States
United States
Employees
3658
713
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HWC
BLLN
Price
$75.18
$118.17
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$77.67
$126.71
AVG Volume (30 Days)
910.1K
737.4K
Earning Date
04-21-2026
05-06-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.59
$46.29
Revenue Next Year
$4.42
$30.14
P/E Ratio
$12.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.05
$61.96
52 Week High
$76.39
$138.70

Technical Indicators

Market Signals
Indicator
HWC
BLLN
Relative Strength Index (RSI) 68.19 62.10
Support Level $66.24 $79.07
Resistance Level N/A $138.70
Average True Range (ATR) 1.53 6.43
MACD 0.20 0.90
Stochastic Oscillator 87.79 76.08

Price Performance

Historical Comparison
HWC
BLLN

About HWC Hancock Whitney Corporation

Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business, and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit, and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations, and individuals and provides its customers access to investment advisory and brokerage products.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: